213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients

BACKGROUND: Allogeneic hematopoietic stem cell transplant (alloHSCT) recipients are at substantial risk for Clostridioides difficile infection (CDI) due to prolonged hospitalization and alteration of the intestinal mucosa and gut microbiota from conditioning regimens, antimicrobials, and immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Lauren, Wright, Kaylor, Luk, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752381/
http://dx.doi.org/10.1093/ofid/ofac492.290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752381/
http://dx.doi.org/10.1093/ofid/ofac492.290

Ejemplares similares